AstraZeneca (AZN -1.2%) completes its acquisition of Pearl Therapeutics, now owning 100% of...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN -1.2%) completes its acquisition of Pearl Therapeutics, now owning 100% of Pearl's shares. The acquisition further expands AZN's reach in the development of inhaled small-molecule therapeutics for respiratory disease, and gives the pharma-giant access to a potential new treatment for chronic obstructive pulmonary disease, currently in late-stage development.